Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

A1 Biochem Labs, LLC Syracuse NY 13218 USA

UEI: SLED_61858A9EFD9ED0CC

A1 Biochem Labs, LLC Syracuse NY 13218 USA is a federal contractor, registered under UEI SLED_61858A9EFD9ED0CC. It has been awarded $112,350 across 1 federal contract. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include National Institutes Of Health Nida.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_61858A9EFD9ED0CC

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

National Institutes Of Health Nida$112.3K100%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$112.3K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in A1 Biochem Labs, LLC Syracuse NY 13218 USA's top NAICS codes and agencies

Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIVThis contract solicits commercial services through a combined synopsis/solicitation under solicitation number 75N95026R0007 issued by the National Institute on Drug Abuse within the National Institutes of Health, Department of Health and Human Services. The requirement is for a firm fixed-price contract to conduct a pharmacoepidemiological study using Veterans Affairs electronic health record data to evaluate the impact of GLP-1 receptor agonists on HIV-related outcomes and alcohol and substance use disorders in adults living with HIV. The study will employ propensity-score matching and multivariable linear regression analysis to assess changes in health outcomes before and after exposure to these medications, with deliverables including aggregate-level findings, support for conference abstracts, and peer-reviewed publications led by NIDA and its collaborators. Performance is expected to occur in Bethesda, Maryland, with a base period running from August 7, 2026, to August 6, 2027, and three optional one-year extension periods through August 6, 2030. The NAICS code is 541690, with a small business size standard of $19.0 million in average annual receipts, and the acquisition is full and open with no set-aside restrictions. The solicitation requires comprehensive offer submissions including detailed technical capability demonstrations and fully loaded pricing for labor categories, hours, other direct costs, and total amounts, along with mandatory representations including UEI, TIN, and active SAM registration. Evaluation will be based on technical capability, past performance, and price, with non-price factors significantly more important than price, indicating a trade-off selection process rather than lowest price technically acceptable. Several FAR clauses are incorporated by reference, including those related to labor standards, equal opportunity, subcontracting, whistleblower rights, cybersecurity, and prohibition of confidentiality agreements that restrict reporting misconduct. Clause 52.222-49 is included in full text due to an unknown place of performance at the time of solicitation, requiring wage determinations to be retroactively applied if needed without price adjustment. Restrictions on data handling are strict: only de-identified, aggregate data may be shared outside VA systems, with no personally identifiable information permitted to leave secure VA servers. Proposals must be submitted electronically by 9:00 a.m. EST on July 30, 2026, to Robin.Knightly@nih.gov, and the contracting officer retains authority to award without further negotiation upon timely acceptance of the best

National Institutes Of Health Nida

POSTED

about 18 hours ago

DEADLINE

Supply of Zinc Oxide Ointment (NSN: 6505001501990)The contract requires the supply of 5,000 tubes of commercial off-the-shelf Zinc Oxide Ointment identified by NSN 6505001501990, with all packaging and labeling fully compliant with Department of Defense medical marking and hazard communication standards. The product must be delivered to Bossier City, LA, with a zip code of 71111-5397, and the supplier is responsible for ensuring that all regulatory and packaging requirements are met to support military medical logistics. The solicitation is classified as a subcontract under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA under the Department of Defense. Responses are due by August 3, 2026, at 5:00 PM, following a posting date of July 26, 2026. There is no set-aside designation specified, and the contract is open to eligible subcontractors meeting the technical and compliance criteria. The place of performance is firmly established in Bossier City, LA, and all delivered units must adhere strictly to DLA standards to ensure seamless integration into military medical supply chains. The official solicitation can be accessed via the provided DIBBS link for complete submission details.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply of Vecuronium Bromide (Anesthetic Agent)The contract is for the supply of freeze-dried Vecuronium Bromide for injection, packaged as 10mg per vial in units of 10 vials, to meet stringent FDA, military, and defense supply chain requirements. The product is an essential anesthetic agent intended for use in critical care and combat medical environments, ensuring readiness and compliance with federal and defense medical protocols. The solicitation is categorized as a subcontract under NAICS code 325412, indicating its focus on pharmaceutical manufacturing, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. The offer response deadline is August 3, 2026, with the contract posted on July 26, 2026, leaving a limited window for qualified suppliers to submit proposals. The place of performance is designated as Joint Base Elmendorf-Richardson in Anchorage, Alaska, with a zip code of 99506-4400, suggesting the end-use location is tied to military medical operations in that region. The contract is accessible via the DIBBS portal, and all supply requirements must align with the defense logistics system, emphasizing packaging integrity, shelf life, traceability, and compliance with DoD procurement standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Hazardous Pharmaceutical Packaging and PreservationThe contract requires the military-standard packaging and preservation of a hazardous, temperature-sensitive pharmaceutical in full compliance with MIL-STD-2073-1E and DLA RP001 specifications. This includes sealing each pharmaceutical unit in protective containers designed to maintain product integrity during transport under demanding environmental conditions, ensuring safety and regulatory adherence throughout the supply chain. All packaging processes must account for the material’s hazardous nature and thermal sensitivity, with strict controls to prevent contamination, degradation, or compromise during handling and transit. The work is to be performed at APO, zip code 09227-0000, under a subcontract agreement issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 26, 2026, with a response deadline of August 3, 2026. The North American Industry Classification System code 325412 indicates the activity pertains to pharmaceutical and medicinal product manufacturing, aligning the scope with specialized production and packaging capabilities. The terms demand precise execution under federal defense standards, emphasizing reliability, traceability, and security in the handling of critical medical materiel.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Electrode Gel Manufacturing and SupplyThe contract entails the manufacture and delivery of a specialized electrode gel designed for EKG applications, requiring the product to be clear, salt-free, non-staining, and corrosion-resistant to ensure optimal performance and patient safety. The gel must be packaged in 8.5 oz tubes, with twelve tubes per box, and must maintain its integrity and effectiveness over a 48-month shelf life, ensuring long-term usability without degradation. Delivery terms specify FOB Destination to Scott AFB, IL, indicating the vendor assumes responsibility for all shipping costs and risks until the product reaches the designated military location. The solicitation is classified as a subcontract under NAICS code 325412, which corresponds to pharmaceutical and medicine manufacturing, and is issued by the Department of Defense through its Medical Supply Chain division. Responses are due by August 3, 2026, with the opportunity posted on July 26, 2026, suggesting a competitive bidding window of approximately one week to secure the supply agreement.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Sodium Chloride Injection (250 mL) SupplyThe contract calls for the supply of FDA-approved, sterile Sodium Chloride Injection, USP, in 250 mL flexible bags, manufactured and packaged to meet stringent USP standards, MMS NO. 1 specifications, and DLA labeling requirements. The product must be suitable for intravenous use and fully compliant with federal regulatory and procurement guidelines for medical supplies within the Department of Defense. All lots must be sterile, pyrogen-free, and consistently meet the quality benchmarks set by the United States Pharmacopeia to ensure patient safety and clinical efficacy. The solicitation is issued under the NAICS code 325412 for pharmaceutical preparation manufacturing and is structured as a subcontract through the Medical Supply Chain Pharm FSA. Responses are due by August 3, 2026, with performance expected to support logistics operations centered at Fort Bragg, North Carolina, under the 28310 zip code. The contract is managed by the Department of Defense and will be administered through the DLA network, requiring strict adherence to packaging, labeling, and documentation standards mandated by DLA to ensure seamless integration into military medical supply chains.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supplier – Dantrolene Sodium for InjectionThe contract solicits the supply of sterile, lyophilized Dantrolene Sodium for Injection, USP, specifically designated for emergency medical use and required to meet stringent regulatory standards including FDA compliance, current Good Manufacturing Practices, and defined shelf-life parameters. The product must be manufactured and packaged to ensure stability, purity, and readiness for immediate deployment in critical care scenarios, with all documentation and labeling adhering to federal pharmaceutical requirements. This is a subcontract under the Department of Defense, managed by the MEDICAL SUPPLY CHAIN PHARM FSA, with performance required at Fort Bragg, North Carolina, 28310. The solicitation was posted on July 26, 2026, with a response deadline of August 3, 2026, targeting qualified pharmaceutical suppliers capable of meeting the technical, regulatory, and logistical demands of emergency medical procurement. The North American Industry Classification System code 325412 indicates the scope is within pharmaceutical preparation manufacturing. There is no set-aside designation specified, and the opportunity is open to eligible subcontractors with proven capacity to deliver compliant, high-integrity Dantrolene Sodium products in a timely and reliable manner, ensuring continuous availability for military and emergency medical operations.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of 3M PETRIFILM E. coli / Coliform Count PlatesThe contract seeks the supply of 3M PETRIFILM E. coli / Coliform Count Plates, specifically dual-indicator dry-film plates designed for the simultaneous detection of E. coli and total coliforms in water and environmental samples. These plates must comply with stringent military packaging, labeling, and traceability requirements to ensure operational readiness and compliance with Department of Defense standards. The product is intended for overseas delivery to a military address in APO 09227-0000, necessitating logistics and documentation that meet strict federal and defense protocols for secure and auditable supply chain management. The solicitation, posted on July 26, 2026, with a response deadline of August 3, 2026, is structured as a subcontract under NAICS code 325412, indicating it relates to the manufacture of industrial chemical products, and is managed by the Medical Supply Chain FSH under the Department of Defense.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Supply of 3M PETRIFILM Coliform Count PlatesThe contract involves the supply of 3M PETRIFILM Coliform Count Plates for the detection and enumeration of coliform bacteria in food, water, and environmental samples, requiring strict adherence to all packaging, labeling, and hazardous materials documentation standards. These dry-film plating media are critical for microbiological testing and must be delivered in full compliance with regulatory and safety protocols to ensure accurate and reliable results in operational settings. The solicitation is classified as a subcontract under NAICS code 325412, issued by the Department of Defense through the Medical Supply Chain FSH, with performance required at APO ZIP 09227-0000. Responses are due by August 3, 2026, and the posting date is July 26, 2026. The procurement is structured to support defense medical and environmental monitoring needs, ensuring a reliable, standardized supply of testing media for coliform detection in field and laboratory environments. All deliveries must meet exacting quality and compliance requirements without exception.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Supply of 3M PETRIFILM Aerobic Count PlatesThe contract is for the supply of ready-to-use, self-contained dry-film plating media specifically designed for aerobic bacterial count testing in food and pharmaceutical applications, with all units required to meet strict compliance standards for packaging, labeling, and documentation. The product, identified as 3M PETRIFILM Aerobic Count Plates, must be delivered to an overseas military consignee at address APO 09227-0000, indicating a global logistics requirement supporting U.S. Department of Defense operations. The procurement is classified as a subcontract under NAICS code 325412, which pertains to other chemical product and preparation manufacturing, and is being managed by the Medical Supply Chain FSH within the Department of Defense. All deliveries must be completed by the response deadline of August 3, 2026, with no set-aside provisions specified, meaning the contract is open to any qualified bidder regardless of business size or ownership status.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Medical Gel Supply – Lidocaine 4% with Aloe VeraThe contract is for the supply of pharmaceutical-grade Lidocaine 4% Gel with Aloe Vera, packaged in boxed units for delivery to Fort Bragg, North Carolina, with a zip code of 28310. The product must meet strict FDA regulations and comply with military packaging standards, ensuring safety, sterility, and uniformity for use in military medical settings. The solicitation was posted on July 26, 2026, and responses are due by August 3, 2026, indicating a compressed timeline for submission and evaluation. Categorized under NAICS code 325412, this subcontract pertains specifically to the manufacturing of pharmaceutical preparations and is managed by the Department of Defense through the MEDICAL SUPPLY CHAIN PHARM FSA. All units must be delivered to the specified location, and the product formulation must consistently deliver the stated concentration of Lidocaine while incorporating Aloe Vera for enhanced skin compatibility and therapeutic benefit.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supplier – DEA Schedule II Controlled SubstanceThe contract requires the supply of three units of Morphine Sulfate Injection at a concentration of 10mg/mL, packaged in NEXJECT single-dose format, fully compliant with FDA, DEA, and DLA packaging and labeling regulations. As a Schedule II controlled substance under the DEA, strict adherence to security, documentation, and distribution protocols is mandatory, reflecting the high regulatory scrutiny applied to this class of pharmaceuticals. The product must meet all federal standards for controlled substances, ensuring safe handling, tracking, and chain-of-custody from manufacturer to final delivery point. This is a subcontract issued under the Department of Defense through the Medical Supply Chain Pharm FSA, with performance required at Joint Base Elmendorf-Richardson, Alaska, identified by zip code 99506-4400. The solicitation was posted on July 26, 2026, and responses are due by August 3, 2026. The NAICS code 325412 indicates this relates to pharmaceutical preparation manufacturing. All bidding entities must demonstrate capability to meet federal control substance handling requirements and deliver in compliance with DLA’s specific packaging and labeling mandates, with no set-aside provisions specified, meaning the opportunity is open to all qualified suppliers.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing & FormulationThe contract pertains to the manufacturing of Ketorolac Tromethamine Injection, USP 15 mg/mL, in prefilled syringes, adhering strictly to current Good Manufacturing Practices, FDA regulations, and USP standards. The product must be produced in a certified facility with full compliance to ensure safety, potency, and consistency, with all processes subject to rigorous quality control and documentation requirements. The scope includes end-to-end production from active pharmaceutical ingredient handling through final packaging, with prefilled syringes meeting specific sterility, particulate, and dosage accuracy specifications outlined by regulatory authorities. This is a subcontract issued by the Department of Defense under the Medical Supply Chain Pharm FSA, with performance required at Fort Bragg, North Carolina, 28310. The solicitation was posted on July 26, 2026, and responses are due by August 3, 2026, indicating a tight turnaround for technical and compliance submissions. The NAICS code 325412 confirms the classification under Pharmaceutical and Botanical Product Manufacturing, and the contract is part of the DoD’s effort to secure a reliable, compliant supply of critical medications for military medical operations. All parties must be prepared to demonstrate capacity for scale, regulatory adherence, and on-time delivery under stringent federal procurement guidelines.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and PackagingThe contract requires the manufacture and packaging of TOLNAFATTE POWDER, USP 1%, in 45 gram units, adhering strictly to USP standards, FDA current good manufacturing practices, and military packaging specifications. Production must meet all quality and regulatory requirements for pharmaceutical products destined for military use, with the finished goods to be delivered to Mountain Home Air Force Base, Idaho, under the designated zip code 83648-1000. The solicitation is categorized as a subcontract under NAICS code 325412, which corresponds to pharmaceutical preparation manufacturing, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. Bids must be submitted by August 3, 2026, with the request publicized on July 26, 2026, and all activities must align with the defense supply chain’s stringent compliance, traceability, and delivery protocols.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Supply Manufacturing – Sodium Chloride InjectionThe contract calls for the manufacture and supply of sterile Sodium Chloride Injection designated by NSN 6505013841365, ensuring full compliance with medical-grade standards for sterility, precise dosage, and complete container integrity. The product must be produced under stringent pharmaceutical protocols to meet military and healthcare requirements, with all batches subject to rigorous quality control to guarantee safety and efficacy. The supplier is expected to deliver consistent, reliable output aligned with regulatory expectations for parenteral solutions used in clinical settings. This is a subcontract under the Department of Defense, managed by the Medical Supply Chain Pharm FSA, with performance location specified at Fort Bragg, North Carolina, ZIP 28310. The solicitation was posted on July 26, 2026, and responses are due by August 3, 2026, indicating a short turnaround window for qualification and proposal submission. The NAICS code 325412 identifies the industry as Pharmaceutical and Medicine Manufacturing, underscoring the specialized production capabilities required. Interested parties must respond through the DIBBS platform using the provided RFQ link, and failure to meet the outlined technical and compliance criteria will result in disqualification.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Povidone-Iodine Topical Solution (Medical Antiseptic)The contract entails the supply and delivery of 10,000 bottles of Povidone-Iodine Topical Solution, USP, to DLA Troop Support, with all products required to meet United States Pharmacopeia standards, Occupational Safety and Health Administration regulations, and specific military labeling requirements to ensure safety and compliance in defense medical applications. The anticipated delivery location is Fort Bragg, North Carolina, with the product intended for use within military medical supply chains. This subcontract was posted on July 26, 2026, and responses must be submitted by August 3, 2026, under NAICS code 325412 for pharmaceutical preparation manufacturing. The contracting organization is the Department of Defense through the Medical Supply Chain Pharm FSA, indicating the order originates from a federal medical logistics division. While no solicitation number or point of contact is provided, all bids must align with exact pharmaceutical and labeling specifications to qualify for award, and the transaction is managed through the DIBBS platform for defense procurement.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Lactated Ringer’s Injection Supply (Pharmaceutical Product Manufacturing)The contract pertains to the supply of Lactated Ringer’s Injection in 1000mL volumes, manufactured to meet stringent USP, FDA, and DLA standards, ensuring compliance with federal pharmaceutical and military medical requirements. This is a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, with performance specifically tied to Dyess Air Force Base, Texas, ZIP 79607-1720. The solicitation is classified under NAICS code 325412, which corresponds to pharmaceutical and botanical product manufacturing, indicating the production must align with pharmaceutical-grade quality controls and good manufacturing practices. The opportunity was posted on July 26, 2026, with a response deadline of August 3, 2026, leaving a narrow window for interested parties to submit proposals. All deliverables must satisfy exacting specifications to support military medical readiness and logistical needs, with no set-aside provisions specified for small business or other categories. The contract’s administration is managed through the DIBBS portal, and successful bidders are expected to provide consistent, high-volume production with strict adherence to regulatory and traceability requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Ringer’s Lactated Injection (500 mL)The contract calls for the manufacture and delivery of sterile Ringer’s Lactated Injection, USP, in 500 mL units, packaged in cases of 24 units per pallet, to meet stringent FDA current Good Manufacturing Practices, defined shelf-life requirements, and specific military packaging and labeling standards. The product must comply with all regulatory and logistical specifications mandated by the Department of Defense, ensuring suitability for use in military medical operations. Delivery is to be performed to Fort Bliss, Texas, with the ZIP code 79918-2527 designated as the place of performance. This subcontract, posted on July 26, 2026, with a response deadline of August 3, 2026, falls under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The contract is administered by the Medical Supply Chain Pharm FSA, a component of the Department of Defense, and is accessible via the DIBBS platform. All bidders must adhere to the technical, quality, and packaging criteria outlined to ensure full compliance with military medical supply protocols, and failure to meet these standards may result in rejection of the proposal.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE